ICU Medical, Inc. $ICUI Shares Acquired by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans grew its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 1,604.0% in the fourth quarter, Holdings Channel reports. The fund owned 303,457 shares of the medical instruments supplier’s stock after purchasing an additional 285,648 shares during the period. Thrivent Financial for Lutherans’ holdings in ICU Medical were worth $43,294,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ICUI. Millennium Management LLC increased its stake in shares of ICU Medical by 173.4% in the 3rd quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock worth $130,638,000 after acquiring an additional 690,694 shares during the last quarter. UBS Group AG increased its position in shares of ICU Medical by 239.8% during the 3rd quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier’s stock worth $46,371,000 after purchasing an additional 272,782 shares during the last quarter. Ameriprise Financial Inc. increased its position in shares of ICU Medical by 34.0% during the 3rd quarter. Ameriprise Financial Inc. now owns 803,542 shares of the medical instruments supplier’s stock worth $96,393,000 after purchasing an additional 203,746 shares during the last quarter. Schroder Investment Management Group increased its position in shares of ICU Medical by 25.2% during the 3rd quarter. Schroder Investment Management Group now owns 796,704 shares of the medical instruments supplier’s stock worth $93,246,000 after purchasing an additional 160,380 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of ICU Medical by 16.9% during the 3rd quarter. Dimensional Fund Advisors LP now owns 872,993 shares of the medical instruments supplier’s stock worth $104,718,000 after purchasing an additional 126,072 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ICUI. Wall Street Zen raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Piper Sandler cut their price objective on ICU Medical from $178.00 to $163.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. Jefferies Financial Group raised ICU Medical to a “strong-buy” rating in a research report on Thursday, May 7th. KeyCorp cut their price objective on ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Finally, Weiss Ratings raised ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $169.00.

ICU Medical Stock Performance

NASDAQ ICUI opened at $118.72 on Friday. The company has a market cap of $2.97 billion, a P/E ratio of 64.17, a P/E/G ratio of 1.71 and a beta of 0.74. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.34 and a quick ratio of 1.17. The stock has a 50-day moving average of $125.92 and a two-hundred day moving average of $138.30. ICU Medical, Inc. has a 1-year low of $107.00 and a 1-year high of $160.29.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.19. The company had revenue of $525.77 million during the quarter, compared to the consensus estimate of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.ICU Medical’s revenue was down 12.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.72 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, analysts anticipate that ICU Medical, Inc. will post 6.31 EPS for the current year.

Insider Activity

In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total value of $303,623.76. Following the completion of the transaction, the vice president directly owned 19,460 shares of the company’s stock, valued at $2,414,596.80. The trade was a 11.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director David C. Greenberg sold 2,424 shares of ICU Medical stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $122.91, for a total value of $297,933.84. Following the completion of the transaction, the director directly owned 7,960 shares of the company’s stock, valued at approximately $978,363.60. This represents a 23.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 2.10% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.